# Pilot Trial for Treatment of Recurrent Glioblastoma

> **NCT05432518** · EARLY_PHASE1 · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 10 (estimated)

## Conditions studied

- Glioblastoma
- Recurrent Disease
- Recurrent Glioblastoma

## Interventions

- **DRUG:** Afatinib
- **DRUG:** Dasatinib
- **DRUG:** Palbociclib
- **DRUG:** Everolimus
- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT05432518
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-27
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05432518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05432518, "Pilot Trial for Treatment of Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05432518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*